New study aims to stop dangerous blood pressure drops during C-Sections
NCT ID NCT07363109
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two drugs, metaraminol and norepinephrine, given as steady infusions to prevent low blood pressure during planned C-sections under spinal anesthesia. 80 women having a single-baby C-section will be randomly assigned to receive one of the drugs right after the spinal block. The goal is to see which drug better prevents drops in blood pressure and reduces the need for extra medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
metaraminol and norepinephrine
What this could lead to
If one drug works better, it could become the standard way to prevent low blood pressure during planned C-sections, making the procedure safer and more comfortable.
What could go wrong
This is a small, early-stage trial with only 80 participants, so results may not apply to all women. Both drugs have risks like slow heart rate or high blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOTENSION AFTER SPINAL ANESTHESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••